120
Participants
Start Date
July 20, 2017
Primary Completion Date
March 12, 2020
Study Completion Date
May 28, 2020
Melphalan
High-dose chemotherapy regimen for conditioning treatment before autologous stem cell Transplantation. Patients will receive melphalan at a total dose of 200mg/m2, divided in two doses of 100mg/m2/day on days -2 and -1, with the ASCT at day 0.
Bendamustine
High-dose chemotherapy regimen for conditioning treatment before autologous stem cell Transplantation. Patients will receive bendamustine at a total dose of 400mg/m2, divided in two doses of 200mg/m2/day on days -4 and -3. Melphalan is given at a total dose of 200mg/m2, divided in two doses of 100mg/m2/day, each on days -2 and -1, with the ASCT at day 0.
Department for Medical Oncology University Hospital/Inselspital, Bern
Mundipharma Medical Company
INDUSTRY
Insel Gruppe AG, University Hospital Bern
OTHER